Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Nutrition supply human beings with the essential amount of carbohydrates, proteins, water, fats, vitamins, and minerals for proper cellular functioning and physiological activities and to maintain energy balance in the body. Clinical nutrition is recommended for patients of all ages including infants, adults, and geriatric, who are susceptible to conditions such as metabolic syndrome, nutrition for patients undergoing surgery or nutrition for patients post-surgery, and others. These factors have led to an increase in demand for clinical nutrition products. According to the American Diabetes Association report 2019, 34.2 million Americans or 10.5% of the population had diabetes in 2018 and according to the same source, around 1.6 million Americans have type 1 diabetes, including about 187,000 children and adolescents. Clinical nutrition is segmented into two different types such as enteral nutrition and parental nutrition, and is important for management of certain chronic conditions such as diabetes, obesity, constipation, malabsorption, indigestion, and others. It also helps to maintain healthy lifestyle, improves appetite and food intake, lowers the risk for nutrient deficiencies, and other health conditions.

The U.S. clinical nutrition market is estimated to be valued at US$ 4,148.9 million in 2020 and is expected to exhibit a CAGR of 5.8% during the forecast period (2020-2027).

Figure 1. U.S. Clinical Nutrition Market Share (%) in Terms of Value, By Application, 2020

U.S. Clinical Nutrition  | Coherent Market Insights

The rising prevalence of chronic diseases is expected to drive the market growth during the forecast period

The increasing prevalence of cancer in the U.S. is expected to drive the market growth over the forecast period. For instance, according to the American Cancer Society report September 2020, Breast cancer is one of the most common type of cancer in the U.S., with 279,100 new cases expected in the U.S. in 2020.

request-sample

U.S. Clinical Nutrition Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 4,148.9 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 5.8% 2027 Value Projection: US$ 6,161.4 Mn
Geographies covered:
  • U.S.
Segments covered:
  • By Nutrition Type:
    • Enteral Nutrition: Standard Nutrition, Disease Specific Nutrition.
    • Parenteral Nutrition: Amino Acid, Carbohydrates, Vitamins and Minerals, Others.
  • By Form: Powder, Liquid, Others.
  • By Age Group: Infant Nutrition, Adult Nutrition, Geriatric Nutrition.
  • By Application: Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases, Other Applications
  • By End User: Hospitals, Ambulatory Surgical Centers, Long Term Care Facilities
Companies covered:

Abbott Laboratories, Baxter International Inc., Fresenius Kabi AG, Nestlé S.A., DANONE S.A., B. Braun Melsungen AG, Mead Johnson & Company LLC,  and Perrigo Company PLC

Growth Drivers:
  • Rising prevalence of chronic diseases
  • Increasing number of product launches
  • Government initiatives, investments, and funding for clinical nutrition research
Restraints & Challenges:
  • Side effects of clinical nutrition
  • High cost nutritional therapy in ICU patients  

Figure 2. U.S. Clinical Nutrition Market Share (%), by End User, 2020

U.S. Clinical Nutrition  | Coherent Market Insights

Increasing government initiatives to spread awareness about clinical nutrition are expected to drive the market growth during the forecast period

Several government and non-government programs are carried out in U.S, in order to spread awareness among people about U.S. Clinical Nutrition Market, which is expected to drive the market growth during the forecast period.

For instance, in October 2015, the National Association of Nutrition and Aging Services Programs (NANASP) announced an increase in the 2-year budget agreement starting in October 2015 and ending in September 2017. Moreover, under the Older Americans Act (OAA) 2017, US$ 83.7 billion for the Supplemental Nutrition Assistance Program (SNAP) was allocated by the then president of the U.S., Mr. Barack Obama.

Thus, increasing awareness about clinical nutrition is expected to drive the market growth during the forecast period.

U.S. Clinical Nutrition Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus (COVID-19) has resulted in more than 109 million infected individuals worldwide as of February 17, 2021.

COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of drugs from one place to another.

Furthermore, players operating in the U.S. Clinical Nutrition Market are facing major challenges on various fronts due to the COVID-19 pandemic. The major challenges include supply of raw materials required for manufacturing clinical nutritional products due to irregularities in transportation. Moreover, distributors of clinical nutritional product are experiencing irregular demand for products from the retailers due to an increase in the number of patients suffering from COVID-19 and other life threatening disorders.

U.S. Clinical Nutrition Market: Restraint

The major factors that is expected to hinder growth of the U.S. clinical nutrition market include side effects and complications caused by excessive consumption of products indicated for clinical nutrition. Excess consumption of any nutritional product can lead to life threating conditions. For instance, excessive consumption of parenteral nutritional therapy can lead to serious and life threating conditions such as liver dysfunction. The serious side effects associated with clinical nutrition include high blood pressure, high cholesterol, heart disease, stroke, and osteoporosis, and these factors are expected to restrain the adoption of clinical nutrition.

Moreover, higher cost of the treatment for critical ICU patients undergoing nutritional therapy is expected to hamper the U.S. clinical nutrition market growth during the forecast period. For instance, according to a study published in the BioMed Central (BMC) in year 2019, patients who survive ICU suffer from severe, prolonged functional disabilities and thus, many patients are likely to be discharged to post-acute care facilities, where the patient requires nutritional support and this could incur costs of approximately US$ 3.5 million/ depending on functioning of patient, in the U.S.

Key Players

Major players operating in the U.S. clinical nutrition market include Abbott Laboratories, Baxter International Inc., Fresenius Kabi AG, Nestlé S.A., DANONE S.A., B. Braun Melsungen AG, Mead Johnson & Company LLC,  and Perrigo Company PLC.

Clinical nutrition involves the study of prevention, diagnosis and management of nutritional and metabolic changes related to various diseases such as diabetes, cancer, metabolic syndrome, Inflammatory Bowel Movement (IBD), and others caused by a lack or excess of energy and nutrients. Clinical nutrition products focus at maintaining a nutritional balance in patients, by delivering adequate amounts of nutrients, such as vitamins, proteins, and minerals. The specialized clinical nutritional feeding known as enteral or parenteral feeding. Enteral nutrition also known as tube feeding. The tube feeding formula is used in patients suffering from chronic conditions including head trauma, cancer, and strokes. Moreover, the enteral nutrition formula helps premature infants to gain required nutrition and medications. Parental nutrition is an intravenous administration of nutrition in critically ill patients. Clinical Nutrition helps to maintain healthy lifestyle, improves appetite and food intake, lowers the risk for nutrient deficiencies, and other health conditions. It i is recommended for patients of all ages including infants, adults, and geriatric who are susceptible to conditions such as metabolic syndrome, nutrition for patients undergoing surgery or nutrition for patients post-surgery and others.

Market Dynamics

Rising prevalence of chronic disease and increasing geriatric population are some of the major factors that are expected to drive growth of the U.S. clinical nutrition market over the forecast period. For instance, according to the U.S. Department of Health and Human Services report published on April 2018, stated that the population of age 65 and older has increased from 37.2 million in 2006 to 49.2 million in 2016, and is estimated to almost double to reach 98 million by 2060.

Key features of the study:

  • This report provides in-depth analysis of the U.S. clinical nutrition market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the U.S. clinical nutrition market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Baxter International Inc., Fresenius Kabi AG, NESTLÉ S.A., DANONE S.A., B. Braun Melsungen AG, Mead Johnson & Company, LLC, and Perrigo Company PLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The U.S. clinical nutrition market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. clinical nutrition market

Detailed Segmentation:

  • U.S. Clinical Nutrition Market, By Nutrition Type:
    • Enteral Nutrition
      • Standard Nutrition
      • Disease Specific Nutrition
    • Parenteral Nutrition
      • Amino Acids
      • Carbohydrates
      • Vitamins and Minerals
      • Others
  • U.S. Clinical Nutrition Market, By Form:
    • Powder
    • Liquid
    • Others
  • U.S. Clinical Nutrition Market, By Age Group:
    • Infant Nutrition
    • Adult Nutrition
    • Geriatric Nutrition
  • U.S. Clinical Nutrition Market, By Application:
    • Diabetes
    • Cancer
    • Critical Care
    • Neurological Disorder
    • Metabolic Syndrome
    • Gastrointestinal Diseases
    • Other Applications
  • U.S. Clinical Nutrition Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Long Term Care Facilities
  • Company Profiles
    • Abbott Laboratories Company*
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Baxter International Inc.
    • Fresenius Kabi AG
    • NESTLÉ S.A.
    • DANONE S.A.
    • B. Braun Melsungen AG
    • Mead Johnson & Company, LLC
    • Perrigo Company PLC

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Nutrition Type
      • Market Snapshot, By Form
      • Market Snapshot, By Age Group 
      • Market Snapshot, By Application
      • Market Snapshot, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • 3.1. Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
      • Impact Analysis
      • Key Developments
      • Top brands for Elderly Patients
      • Market Trends
      • Epidemiology
      • Regulatory Scenario
      • PEST Analysis
      • Global Clinical Nutrition Market Overview
    • 3.2. U.S. Annual sales For Clinical Nutrition Products, 2016-2027
      • Abbott Nutrition
      • Ensure(R) Surgery Immunonutrition shakes
      • Nestle
      • Peptamen(R) AF Formula
      • Peptamen(R) Intense VHP
      • Impact(R) Advanced Recovery Drink
      • Impact(R) Formula
      • Impact(R) Peptide 1.5 Formula
      • Omegaven
      • SMOFlipid
  4. U.S. Clinical Nutrition Market – Impact of Coronavirus (COVID-19) Pandemic
    • Economic Impact
    • Research and Development
    • COVID -19 Epidemiology
  5. U.S. Clinical Nutrition Market, By Nutrition Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Enteral Nutrition
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Standard Nutrition
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Disease Specific Nutrition
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Parenteral Nutrition
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Amino Acids
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Carbohydrates
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Vitamins and Minerals
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Others
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. U.S. Clinical Nutrition Market, By Form, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Powder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Liquid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. U.S. Clinical Nutrition Market By Age Group, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Infant Nutrition
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Adult Nutrition
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Geriatric Nutrition
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. U.S. Clinical Nutrition Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Critical care
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Neurological Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Metabolic Syndrome
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Gastrointestinal Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Other Application
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  9. U.S. Clinical Nutrition Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Long Term Care Facilities
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  10. Competitive Landscape
    • Competitive Snapshot
    • Heat Map Analysis
    • Company Profile
      • Abbott Laboratories
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Baxter International Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Fresenius Kabi AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • NESTLÉ S.A.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • DANONE S.A.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Braun Melsungen AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Mead Johnson & Company, LLC
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Perrigo Company PLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  11. Section
    • Research Methodology
    • About us and Sales Contact

*Browse 18 market data tables and 31 figures on "U.S. Clinical Nutrition Market” - Global forecast to 2027

Frequently Asked Questions

The U.S. Clinical Nutrition Market is estimated to be valued at US$ 4,148.9 million in 2020 and is expected to exhibit a CAGR of 5.8% between 2020 and 2027.
Factors such as rising prevalence of chronic diseases and increasing government initiatives to spread awareness about clinical nutrition products are expected to drive the market growth during the forecast period.
Enteral nutrition segment is expected to hold major market share during the forecast period, owing to increasing product approvals and launches.
The major factors hampering growth of the U.S. clinical nutrition market include side effects and complications caused by excessive consumption of products indicated for clinical nutrition.
Major players operating in the market include Abbott Laboratories, Baxter International Inc., Fresenius Kabi AG, Nestlé S.A., DANONE S.A., B. Braun Melsungen AG, Mead Johnson & Company LLC, and Perrigo Company PLC
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner